These experiments indicate that regardless of the injection route, BAFF-deficient CLL cells can only home, survive and expand in the peritoneal cavity in the absence of BAFF but are fully competent precursors of progressive CLL in WT hosts. The gene discussed is TNFSF13B; the disease is B-cell chronic lymphocytic leukemia.